Regulation of Nucleotide Excision Repair by Proteolysis
蛋白水解调节核苷酸切除修复
基本信息
- 批准号:7073492
- 负责人:
- 金额:$ 33.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Nucleotide excision repair (NER) plays an important role in maintaining genomic integrity through removing helix-distorting DNA damages caused by UV irradiation or chemical mutagens. Defects in NER underlie the human hereditary disease, xeroderma pigmentosum, which is characterized as sensitivity to ultraviolet light and a high incidence of skin cancer. Studies of NER have been focused on identifying components and the biochemistry of excision and repair reactions, while little is known about the regulatory mechanisms cells employ to control the NER activity. The Cullin 4A ubiquitination machinery has recently been shown to mediate ubiquitin-dependent proteolysis of the p48 subunit of damaged DNA binding proteins that are believed to participate in the initial DNA damage recognition step of NER. Our long-range goal is to understand how the ubiquitin-proteolytic pathway regulates NER, and to relate this understanding to human diseases associated with defective NER as well as the malfunctions of the ubiquitination machinery. The objective of this application is to understand the molecular basis, the regulatory pathways, and the functional significance of CUL-4A-mediated p48 degradation in controlling the damage-sensing step of nucleotide excision repair. The central hypothesis of the application is that the CUL-4A ubiquitination machinery controls the ability of the NER machinery to recognize and remove specific DNA damages through restricting the abundance of p48. The specific aims proposed are (1) To determine the molecular basis for CUL- 4A/DDB interactions and for subcellular distribution of DDB proteins. (2) To determine the functional significance of CUL-4A in DNA damage recognition and repair. (3) To assess the role of c-Abl in regulating p48 degradation and nucleotide excision repair. The results of this work will provide a new paradigm for the regulation of nucleotide excision repair by ubiquitin-dependent proteolysis, and generate a better understanding of the biochemical mechanisms controlling the intracellular distribution and abundance of DDB proteins. Completion of the proposed studies will also shed light on how abnormal activation of CUL- 4A contributes to tumor development.
描述(由申请人提供):核苷酸切除修复(NER)通过消除由紫外线照射或化学诱变剂引起的螺旋扭曲DNA损伤,在维持基因组完整性方面发挥着重要作用。 NER 的缺陷是人类遗传性疾病着色性干皮病的基础,该疾病的特点是对紫外线敏感和皮肤癌的高发病率。 NER 的研究主要集中于识别切除和修复反应的成分和生物化学,而对于细胞用于控制 NER 活性的调节机制知之甚少。 Cullin 4A 泛素化机制最近被证明可以介导受损 DNA 结合蛋白 p48 亚基的泛素依赖性蛋白水解,这些蛋白被认为参与 NER 的初始 DNA 损伤识别步骤。我们的长期目标是了解泛素蛋白水解途径如何调节 NER,并将这种理解与与 NER 缺陷相关的人类疾病以及泛素化机制的故障联系起来。本申请的目的是了解 CUL-4A 介导的 p48 降解的分子基础、调节途径以及在控制核苷酸切除修复的损伤感知步骤中的功能意义。该申请的中心假设是,CUL-4A 泛素化机制通过限制 p48 的丰度来控制 NER 机制识别和消除特定 DNA 损伤的能力。提出的具体目标是 (1) 确定 CUL-4A/DDB 相互作用和 DDB 蛋白的亚细胞分布的分子基础。 (2)确定CUL-4A在DNA损伤识别和修复中的功能意义。 (3)评估c-Abl在调节p48降解和核苷酸切除修复中的作用。这项工作的结果将为泛素依赖性蛋白水解调节核苷酸切除修复提供新的范例,并更好地理解控制 DDB 蛋白的细胞内分布和丰度的生化机制。拟议研究的完成还将揭示 CUL-4A 的异常激活如何促进肿瘤的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pengbo Zhou其他文献
Pengbo Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pengbo Zhou', 18)}}的其他基金
Small Molecule CUL4 Inhibitors as Dual Precision Oncology and Immuno-Oncology Drugs
小分子 CUL4 抑制剂作为双重精准肿瘤学和免疫肿瘤学药物
- 批准号:
10673021 - 财政年份:2022
- 资助金额:
$ 33.14万 - 项目类别:
G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis
G3BP1 抑制 SPOP 泛素连接酶促进前列腺肿瘤发生
- 批准号:
10328476 - 财政年份:2018
- 资助金额:
$ 33.14万 - 项目类别:
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
利用 CRL4 泛素连接酶对抗结直肠癌的发生
- 批准号:
9261925 - 财政年份:2017
- 资助金额:
$ 33.14万 - 项目类别:
Development of high throughput assays to identify small molecule inhibitors of th
开发高通量测定法来鉴定小分子抑制剂
- 批准号:
8103587 - 财政年份:2011
- 资助金额:
$ 33.14万 - 项目类别:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
HOXA9 在白血病发生中的泛素蛋白水解控制
- 批准号:
7016787 - 财政年份:2006
- 资助金额:
$ 33.14万 - 项目类别:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
HOXA9 在白血病发生中的泛素蛋白水解控制
- 批准号:
7336353 - 财政年份:2006
- 资助金额:
$ 33.14万 - 项目类别:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
HOXA9 在白血病发生中的泛素蛋白水解控制
- 批准号:
7173460 - 财政年份:2006
- 资助金额:
$ 33.14万 - 项目类别:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
HOXA9 在白血病发生中的泛素蛋白水解控制
- 批准号:
7754060 - 财政年份:2006
- 资助金额:
$ 33.14万 - 项目类别:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
HOXA9 在白血病发生中的泛素蛋白水解控制
- 批准号:
7547053 - 财政年份:2006
- 资助金额:
$ 33.14万 - 项目类别:
Regulation of Nucleotide Excision Repair by Proteolysis
蛋白水解调节核苷酸切除修复
- 批准号:
8245783 - 财政年份:2003
- 资助金额:
$ 33.14万 - 项目类别:
相似海外基金
N6-methyladenosine (m6A) Interplays with RNA and DNA Damage to Regulate DNA Repair
N6-甲基腺苷 (m6A) 与 RNA 和 DNA 损伤相互作用以调节 DNA 修复
- 批准号:
10835455 - 财政年份:2023
- 资助金额:
$ 33.14万 - 项目类别:
N6-methyladenosine (m6A) Interplays with RNA and DNA Damage to Regulate DNA Repair
N6-甲基腺苷 (m6A) 与 RNA 和 DNA 损伤相互作用以调节 DNA 修复
- 批准号:
10649063 - 财政年份:2023
- 资助金额:
$ 33.14万 - 项目类别:
Dual roles of AID/APOBECs in DNA damage and DNA repair
AID/APOBEC在DNA损伤和DNA修复中的双重作用
- 批准号:
573593-2022 - 财政年份:2022
- 资助金额:
$ 33.14万 - 项目类别:
University Undergraduate Student Research Awards
Measuring genomic DNA damage and DNA repair capacity in longitudinal population samples - a step towards precision prevention
测量纵向群体样本中的基因组 DNA 损伤和 DNA 修复能力——迈向精准预防的一步
- 批准号:
9767787 - 财政年份:2018
- 资助金额:
$ 33.14万 - 项目类别:
Measuring genomic DNA damage and DNA repair capacity in longitudinal population samples - a step towards precision prevention
测量纵向群体样本中的基因组 DNA 损伤和 DNA 修复能力——迈向精准预防的一步
- 批准号:
10817292 - 财政年份:2018
- 资助金额:
$ 33.14万 - 项目类别:
Measuring genomic DNA damage and DNA repair capacity in longitudinal population samples - a step towards precision prevention
测量纵向群体样本中的基因组 DNA 损伤和 DNA 修复能力——迈向精准预防的一步
- 批准号:
10202602 - 财政年份:2018
- 资助金额:
$ 33.14万 - 项目类别:
Measuring genomic DNA damage and DNA repair capacity in longitudinal population samples - a step towards precision prevention
测量纵向群体样本中的基因组 DNA 损伤和 DNA 修复能力——迈向精准预防的一步
- 批准号:
10440390 - 财政年份:2018
- 资助金额:
$ 33.14万 - 项目类别:
Transcriptional regulation and DNA repair mechanism of HSF1-PARP complex by DNA damage stimulation
DNA损伤刺激HSF1-PARP复合物的转录调控和DNA修复机制
- 批准号:
16K07256 - 财政年份:2016
- 资助金额:
$ 33.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of DNA repair mutations and DNA damage in the response to immune checkpoint blockade
DNA 修复突变和 DNA 损伤在免疫检查点封锁反应中的作用
- 批准号:
1796900 - 财政年份:2016
- 资助金额:
$ 33.14万 - 项目类别:
Studentship
Regulation of DNA repair pathway choice by early DNA damage response factors.
早期 DNA 损伤反应因子对 DNA 修复途径选择的调节。
- 批准号:
15K00536 - 财政年份:2015
- 资助金额:
$ 33.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




